Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,340.00
-10.00 (-0.16%)
At close: Apr 28, 2026
-2.01%
Market Cap 72.13B
Revenue (ttm) 80.56B
Net Income (ttm) 7.53B
Shares Out 11.38M
EPS (ttm) n/a
PE Ratio 9.58
Forward PE n/a
Dividend 190.00 (2.99%)
Ex-Dividend Date Dec 29, 2025
Volume 18,718
Average Volume 25,473
Open 6,200.00
Previous Close 6,350.00
Day's Range 6,200.00 - 6,350.00
52-Week Range 5,640.00 - 7,200.00
Beta 0.61
RSI 55.50
Earnings Date Mar 3, 2026

About Sinil Pharmaceutical

Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In ... [Read more]

Industry Pharmaceutical Preparations
Founded 1971
Employees 287
Stock Exchange KOSDAQ
Ticker Symbol 012790
Full Company Profile

Financial Performance

In 2025, Sinil Pharmaceutical's revenue was 80.56 billion, a decrease of -9.92% compared to the previous year's 89.44 billion. Earnings were 7.53 billion, a decrease of -47.34%.

Financial Statements

News

There is no news available yet.